EUVIMEDEUVIMED entdecken
Crossref

Development and Characterization of Oral Disintegrating Films Incorporated with Inclusion Complex of Zotepine

Mo Zaid Ajmeri, Krishna D. Taretiya, Jitendra O. Bhangale

International Journal of Drug Delivery Technology · 19.05.2026 · 16 (30s)

DOI: 10.25258/ijddt.16.30s.32 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.05.2026. Verfasst von Mo Zaid Ajmeri und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to develop and characterize oral disintegrating films (ODFs) of Zotepine, a poorly water-soluble atypical antipsychotic drug, to enhance its solubility, dissolution rate, and bioavailability. Zotepine exhibits limited aqueous solubility and undergoes extensive first-pass metabolism, which restricts its therapeutic effectiveness. To overcome these limitations, β-cyclodextrin inclusion complexation was employed as a solubility enhancement technique. Preformulation studies, including melting point determination and UV spectrophotometric analysis, confirmed the identity and purity of the drug. The observed melting point (87–92 °C) and λmax at 235 nm validated the authenticity of Zotepine, while compatibility studies indicated no significant drug–excipient interactions. Inclusion complexes were prepared and demonstrated a significant improvement in solubility and drug release compared to the pure drug. These complexes were further incorporated into ODFs using suitable film-forming polymers and plasticizers. A 3² factorial design was applied to optimize formulation variables, and the prepared films were evaluated for physicochemical and mechanical properties. Among all formulations, batch ZF3 exhibited optimal performance, showing rapid disintegration (~20 seconds) and maximum drug release (~99% within 12 minutes). Statistical analysis confirmed excellent model fitting with high correlation coefficients (R² ≈ 0.999). Accelerated stability studies revealed no significant changes in formulation characteristics, confirming stability

Zitieren

APA

Ajmeri, M. Z., Taretiya, K. D., & Bhangale, J. O. (2026). Development and Characterization of Oral Disintegrating Films Incorporated with Inclusion Complex of Zotepine. International Journal of Drug Delivery Technology, 16(30s). https://doi.org/10.25258/ijddt.16.30s.32

Vancouver

Ajmeri MZ, Taretiya KD, Bhangale JO. Development and Characterization of Oral Disintegrating Films Incorporated with Inclusion Complex of Zotepine. International Journal of Drug Delivery Technology. 2026;16(30s). doi:10.25258/ijddt.16.30s.32

BibTeX
@article{Ajmeri2026,
  author = {Ajmeri, Mo Zaid and Taretiya, Krishna D. and Bhangale, Jitendra O.},
  title = {Development and Characterization of Oral Disintegrating Films Incorporated with Inclusion Complex of Zotepine},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {30s},
  doi = {10.25258/ijddt.16.30s.32}
}
Kostenlos starten →